HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics Plc (NBRV), sold 21,055 shares at $10.53 ($222K) on 2017-07-14, disclosed to the SEC on 2017-07-18.
Open-market sale of $222k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |